Appello Pharmaceuticals Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $27M

  • Investors
  • 5

Appello Pharmaceuticals General Information

Description

Developer of allosteric modulators designed to help treat Parkinson's disease. The company's modulators specialize in positive allosteric and focus on identifying and developing innovative early-stage drug candidates for patients living with disorders of the nervous system, enabling pharmaceutical developers and clinical partners to address unmet needs in neurological disease and improve patient outcomes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4015 Hillsboro Pike 222
  • Suite 417
  • Nashville, TN 37215
  • United States
+1 (615)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 4015 Hillsboro Pike 222
  • Suite 417
  • Nashville, TN 37215
  • United States
+1 (615)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Appello Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 13-Nov-2024 $27M Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B) 24-Jan-2022 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 13-Nov-2020 Completed Startup
2. Early Stage VC (Series A) 25-Jun-2018 $15.5M $15.5M Completed Startup
1. University Spin-Out 01-Jan-2017 Completed Startup
To view Appello Pharmaceuticals’s complete valuation and funding history, request access »

Appello Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 3,126,893 $0.001000 8% $5 $5 1x $5 26.23%
To view Appello Pharmaceuticals’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Appello Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of allosteric modulators designed to help treat Parkinson's disease. The company's modulators specialize in po
Drug Discovery
Nashville, TN
7 As of 2026

Redwood City, CA
 

Richmond, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Appello Pharmaceuticals Competitors (47)

One of Appello Pharmaceuticals’s 47 competitors is XWPharma, a Venture Capital-Backed company based in Redwood City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
XWPharma Venture Capital-Backed Redwood City, CA
Sangamo Therapeutics Formerly VC-backed Richmond, CA
Angiochem Formerly VC-backed Westmount, Canada
Minerva Neurosciences Formerly VC-backed Burlington, MA
PAQ Therapeutics Venture Capital-Backed Cambridge, MA
You’re viewing 5 of 47 competitors. Get the full list »

Appello Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Appello Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Relevance Ventures Venture Capital Minority
Alexandria Venture Investments Venture Capital Minority
Deerfield Management Venture Capital Minority
Mountain Group Partners Venture Capital Minority
Vanderbilt University University Minority
To view Appello Pharmaceuticals’s complete investors history, request access »

Appello Pharmaceuticals FAQs

  • When was Appello Pharmaceuticals founded?

    Appello Pharmaceuticals was founded in 2017.

  • Where is Appello Pharmaceuticals headquartered?

    Appello Pharmaceuticals is headquartered in Nashville, TN.

  • What is the size of Appello Pharmaceuticals?

    Appello Pharmaceuticals has 7 total employees.

  • What industry is Appello Pharmaceuticals in?

    Appello Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Appello Pharmaceuticals a private or public company?

    Appello Pharmaceuticals is a Private company.

  • What is the current valuation of Appello Pharmaceuticals?

    The current valuation of Appello Pharmaceuticals is .

  • What is Appello Pharmaceuticals’s current revenue?

    The current revenue for Appello Pharmaceuticals is .

  • How much funding has Appello Pharmaceuticals raised over time?

    Appello Pharmaceuticals has raised $59.1M.

  • Who are Appello Pharmaceuticals’s investors?

    Relevance Ventures, Alexandria Venture Investments, Deerfield Management, Mountain Group Partners, and Vanderbilt University have invested in Appello Pharmaceuticals.

  • Who are Appello Pharmaceuticals’s competitors?

    XWPharma, Sangamo Therapeutics, Angiochem, Minerva Neurosciences, and PAQ Therapeutics are some of the 47 competitors of Appello Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process